| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis, parkinsonism and cognitive impairment
|
Rejdak, Konrad
|
|
|
42 |
C |
p.
|
artikel
|
| 2 |
A fine balance: Immunosuppression and immunotherapy in a patient with multiple sclerosis and COVID-19
|
Valencia-Sanchez, Cristina
|
|
|
42 |
C |
p.
|
artikel
|
| 3 |
Alemtuzumab and prescription medication use in the MS population
|
Chertcoff, Anibal
|
|
|
42 |
C |
p.
|
artikel
|
| 4 |
Allogeneic haematopoietic stem cell transplantation in a refractory case of neuromyelitis optica spectrum disorder
|
Hau, Lídia
|
|
|
42 |
C |
p.
|
artikel
|
| 5 |
Anti-CD20 and COVID-19 in multiple sclerosis and related disorders: A case series of 60 patients from Madrid, Spain
|
Montero-Escribano, Paloma
|
|
|
42 |
C |
p.
|
artikel
|
| 6 |
AQP4-IgG may cause muscle damage in patients with neuromyelitis optica spectrum disorder
|
Zhang, Ying
|
|
|
42 |
C |
p.
|
artikel
|
| 7 |
Are type 1 interferons treatment in Multiple Sclerosis as a potential therapy against COVID-19?
|
Gemcioglu, Emin
|
|
|
42 |
C |
p.
|
artikel
|
| 8 |
Assessing balance in non-disabled subjects with multiple sclerosis: Validation of the Fullerton Advanced Balance Scale
|
Mestanza Mattos, Fabiola Giovanna
|
|
|
42 |
C |
p.
|
artikel
|
| 9 |
Beneficial effects of intravenous immunoglobulin as an add-on therapy to azathioprine for NMO-IgG-seropositive neuromyelitis optica spectrum disorders
|
Lim, Young-Min
|
|
|
42 |
C |
p.
|
artikel
|
| 10 |
Benign course of COVID-19 in a multiple sclerosis patient treated with Ocrelizumab
|
Suwanwongse, Kulachanya
|
|
|
42 |
C |
p.
|
artikel
|
| 11 |
Bone health in neuromyelitis optica: Bone mineral density and fractures
|
Kwon, Young Nam
|
|
|
42 |
C |
p.
|
artikel
|
| 12 |
Brain magnetic resonance imaging features in multiple sclerosis and neuromyelitis optica spectrum disorders patients with or without aquaporin-4 antibody in a Latin American population
|
Silveira, Facundo
|
|
|
42 |
C |
p.
|
artikel
|
| 13 |
Changes in patient and physician attitudes resulting from COVID-19 in neuromyelitis optica spectrum disorder and multiple sclerosis
|
Salama, Sara
|
|
|
42 |
C |
p.
|
artikel
|
| 14 |
Childhood infections, vaccinations, and tonsillectomy and risk of first clinical diagnosis of CNS demyelination in the Ausimmune Study
|
Hughes, A.M.
|
|
|
42 |
C |
p.
|
artikel
|
| 15 |
Clinical analysis of anti-NMDAR encephalitis combined with MOG antibody in children
|
Hou, Chi
|
|
|
42 |
C |
p.
|
artikel
|
| 16 |
Clinical and patient determinants of changing therapy in relapsing-remitting multiple sclerosis (SWITCH study)
|
Patti, Francesco
|
|
|
42 |
C |
p.
|
artikel
|
| 17 |
CLIPPERS, a syndrome of lymphohistiocytic disorders
|
Li, Zhibin
|
|
|
42 |
C |
p.
|
artikel
|
| 18 |
Co-existence of multiple sclerosis and anti-NMDA receptor encephalitis: A case report and review of literature
|
Gulec, Bade
|
|
|
42 |
C |
p.
|
artikel
|
| 19 |
Cognitive reserve is a determinant of social and occupational attainment in patients with pediatric and adult onset multiple sclerosis
|
E, Portaccio
|
|
|
42 |
C |
p.
|
artikel
|
| 20 |
COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?
|
Novi, Giovanni
|
|
|
42 |
C |
p.
|
artikel
|
| 21 |
COVID-19 in persons with multiple sclerosis treated with ocrelizumab – A pharmacovigilance case series
|
Hughes, Richard
|
|
|
42 |
C |
p.
|
artikel
|
| 22 |
COVID-19 pandemic: The experience of a multiple sclerosis centre in Chile
|
Ciampi, Ethel
|
|
|
42 |
C |
p.
|
artikel
|
| 23 |
Cryptococcal meningitis in a patient with multiple sclerosis on dimethyl fumarate treatment: A case report
|
Workel, H.H.
|
|
|
42 |
C |
p.
|
artikel
|
| 24 |
Development and validation of the self-reported disability status scale (SRDSS) to estimate EDSS-categories
|
Kaufmann, Marco
|
|
|
42 |
C |
p.
|
artikel
|
| 25 |
Diagnosis-specific sickness absence and disability pension before and after multiple sclerosis diagnosis: An 8-year nationwide longitudinal cohort study with matched references
|
Murley, Chantelle
|
|
|
42 |
C |
p.
|
artikel
|
| 26 |
Discriminative ability of fall efficacy scale international in Iranian people with multiple sclerosis
|
Choobsaz, Haniyeh
|
|
|
42 |
C |
p.
|
artikel
|
| 27 |
Does disability level impact the relationship of muscle strength to walking performance in people with multiple sclerosis? a cross-sectional analysis
|
Mañago, Mark M.
|
|
|
42 |
C |
p.
|
artikel
|
| 28 |
Drug reaction with eosinophilia and systemic symptoms after ocrelizumab therapy
|
Nylund, Marjo
|
|
|
42 |
C |
p.
|
artikel
|
| 29 |
Effectiveness and safety profile of anakinra in a HLA-B27 positive patient with multiple sclerosis-associated uveitis
|
Lopalco, Giuseppe
|
|
|
42 |
C |
p.
|
artikel
|
| 30 |
Eligibility and implementation of disease-modifying therapy for primary progressive multiple sclerosis in a UK cohort
|
Tallantyre, Emma C
|
|
|
42 |
C |
p.
|
artikel
|
| 31 |
Evaluation of types of psychological disorders in patients with neuromyelitis optica spectrum disorder (NMOSD)
|
Ebadi, Zahra
|
|
|
42 |
C |
p.
|
artikel
|
| 32 |
Feasibility study of a 10-week community-based program using the WalkWithMe application on physical activity, walking, fatigue and cognition in persons with Multiple Sclerosis
|
Van Geel, Fanny
|
|
|
42 |
C |
p.
|
artikel
|
| 33 |
First therapy choice in newly diagnosed Multiple Sclerosis patients: A multicenter Italian study
|
Maniscalco, Giorgia T.
|
|
|
42 |
C |
p.
|
artikel
|
| 34 |
Follow-Ups with callers of a palliative and hospice care hotline for severely affected multiple sclerosis patients: Evaluation of its impact
|
Strupp, Julia
|
|
|
42 |
C |
p.
|
artikel
|
| 35 |
From Baló’s concentric sclerosis to multiple sclerosis: a series of 6 patients
|
Ayrignac, Xavier
|
|
|
42 |
C |
p.
|
artikel
|
| 36 |
Identifying the relevant determinants of MS related fatigue: The role of the clinical indicators of disease and personality
|
Matesic, I
|
|
|
42 |
C |
p.
|
artikel
|
| 37 |
Inclusion of the Symbol Digit Modalities Test in a revised assessment of ‘no evidence of disease activity-4 (NEDA-4)’ in Latin-American patients with multiple sclerosis
|
Guevara, Carlos
|
|
|
42 |
C |
p.
|
artikel
|
| 38 |
Is Asian type MS an MS phenotype, an NMO spectrum disorder, or a MOG-IgG related disease?
|
Papais Alvarenga, Regina Maria
|
|
|
42 |
C |
p.
|
artikel
|
| 39 |
‘Is RLS a harbinger and consequence of MS?: Striking results of the ‘RELOMS-T’ study’
|
Sevim, Serhan
|
|
|
42 |
C |
p.
|
artikel
|
| 40 |
Knowledge regarding COVID-19 pandemic in patients with multiple sclerosis (MS): A report from Iran
|
Sahraian, Mohammad Ali
|
|
|
42 |
C |
p.
|
artikel
|
| 41 |
Liver injury after methylprednisolone pulse therapy in multiple sclerosis is usually due to idiosyncratic drug-induced toxicity rather than autoimmune hepatitis
|
Kimura, Hiroko
|
|
|
42 |
C |
p.
|
artikel
|
| 42 |
Longitudinal ultra-high field MRI of brain lesions in neuromyelitis optica spectrum disorders
|
Chawla, Sanjeev
|
|
|
42 |
C |
p.
|
artikel
|
| 43 |
Medication beliefs in first-line and second-line treated multiple sclerosis patients
|
Pust, Gesa Elena Albertine
|
|
|
42 |
C |
p.
|
artikel
|
| 44 |
Meeting report: “Human endogenous retroviruses: HERVs or transposable elements in autoimmune, chronic inflammatory and degenerative diseases or cancer”, Lyon, France, november 5th and 6th 2019 – an MS scientist's digest
|
Kremer, David
|
|
|
42 |
C |
p.
|
artikel
|
| 45 |
MOG-antibody-associated hypertrophic pachymeningitis
|
Papathanasiou, Athanasios
|
|
|
42 |
C |
p.
|
artikel
|
| 46 |
Multiple cervical dissections after Rituximab
|
Roux, Thomas
|
|
|
42 |
C |
p.
|
artikel
|
| 47 |
Multiple intracranial lesions with lung adenocarcinoma: A rare case of MOG-IgG-associated encephalomyelitis
|
Li, Ke
|
|
|
42 |
C |
p.
|
artikel
|
| 48 |
Multiple Sclerosis in sub-Saharan Africa – a scoping review
|
Heine, Martin
|
|
|
42 |
C |
p.
|
artikel
|
| 49 |
Neuroplasticity and brain reorganization associated with positive outcomes of multidisciplinary rehabilitation in progressive multiple sclerosis: A fMRI study
|
Péran, Patrice
|
|
|
42 |
C |
p.
|
artikel
|
| 50 |
Optic nerve atrophy and whole and regional brain atrophy in Leber's hereditary optic neuropathy with multiple sclerosis-like disease with m.11778G>A mutation
|
Rościszewska-Żukowska, Iwona
|
|
|
42 |
C |
p.
|
artikel
|
| 51 |
Overlapping demyelinating syndrome (Neuromyelitis optica spectrum disorders NMOSD with anti-NMDA receptor encephalitis); A case report
|
Sinani, Ahmed Al
|
|
|
42 |
C |
p.
|
artikel
|
| 52 |
Paraneoplastic tumefactive demyelination in a 47-year-old man with underlying seminoma
|
Van Haver, Anne-Sophie
|
|
|
42 |
C |
p.
|
artikel
|
| 53 |
Pilot study of social cognitive theory variables as correlates of physical activity among adolescents with pediatric multiple sclerosis
|
Elizabeth Morghen, Sikes
|
|
|
42 |
C |
p.
|
artikel
|
| 54 |
Real-world incidence of fingolimod-associated macular oedema
|
Goh, Li Yen
|
|
|
42 |
C |
p.
|
artikel
|
| 55 |
Rethinking high-risk groups in COVID-19
|
Vishnevetsky, Anastasia
|
|
|
42 |
C |
p.
|
artikel
|
| 56 |
Safety and feasibility of various fasting-mimicking diets among people with multiple sclerosis
|
Roman, S.N.
|
|
|
42 |
C |
p.
|
artikel
|
| 57 |
Seizure occurrence in myelin oligodendrocyte glycoprotein antibody-associated disease: A systematic review and meta-analysis
|
Shen, Chun-Hong
|
|
|
42 |
C |
p.
|
artikel
|
| 58 |
Severe COVID-19 infection in a patient with multiple sclerosis treated with fingolimod
|
Foerch, Christian
|
|
|
42 |
C |
p.
|
artikel
|
| 59 |
Successful disease control with alemtuzumab in MOG-IgG-associated demyelinating disease with MS-phenotype
|
Otto, Ferdinand
|
|
|
42 |
C |
p.
|
artikel
|
| 60 |
The big challenge for neurologists in treating patients with multiple sclerosis in the post-COVID-19 era
|
Naser Moghadasi, Abdorreza
|
|
|
42 |
C |
p.
|
artikel
|
| 61 |
The importance of being a neurologist (during a dramatic pandemic)
|
Gelibter, Stefano
|
|
|
42 |
C |
p.
|
artikel
|
| 62 |
The possible beneficial effects of higher vitamin B6 intake from diet on cognitive function of patients with neuromyelitis optica spectrum disorder
|
Rezaeimanesh, Nasim
|
|
|
42 |
C |
p.
|
artikel
|
| 63 |
Tonsillectomy in multiple sclerosis patients: Retrospective, case-controlled, exploratory study
|
Jakimovski, Dejan
|
|
|
42 |
C |
p.
|
artikel
|
| 64 |
Validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in a Colombian Population
|
Alarcón, Andrea N.
|
|
|
42 |
C |
p.
|
artikel
|
| 65 |
Validation of the Neuronorma battery for neuropsychological assessment in multiple sclerosis
|
Matías-Guiu, Jordi A.
|
|
|
42 |
C |
p.
|
artikel
|
| 66 |
Walking and cognitive performance in adults with multiple sclerosis: Do age and fatigability matter?
|
Jones, C. Danielle
|
|
|
42 |
C |
p.
|
artikel
|
Tijdschrift beschrijving